TY - JOUR
T1 - Geographic access to gynecologic cancer care in the United States
AU - Shalowitz, David I.
AU - Vinograd, Alexandra M.
AU - Giuntoli, Robert L.
N1 - Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Background Women who live distant from the closest subspecialty treatment center are at risk of failing to utilize high-quality care for gynecologic cancers. There has not yet been a comprehensive, national investigation of populations affected by geographic barriers to gynecologic cancer care. Methods Geographic Information Systems (GIS) were used to identify United States counties farther than 50 miles from the closest gynecologic oncologist, and hospital referral regions (HRRs) that do not contain the primary professional address of at least one gynecologic oncologist. US Census data were used to analyze counties' demographic characteristics. County-level cancer incidence was estimated using the Centers for Disease Control and Prevention's State Cancer Profiles. Results Thirty-six percent (1125/3143) of counties are further than 50 miles from the nearest gynecologic oncologist. A total of 14.8 million women live in low-access counties (LACs). Annually, approximately 7663 women with gynecologic cancers may experience geography-related disparities in access. Residents of LACs have lower median household income, are more likely to be White and/or Hispanic, and less likely to be Black. Forty percent (123/306) of HRRs do not contain the primary address of a gynecologic oncologist. Conclusions Approximately 9% of the female population of the United States may experience geographic barriers to access high-quality care for gynecologic malignancies. Future investigations should assess whether residents of low-access counties utilize high-quality care less often, and whether there is a disparity in clinical outcomes. Disparities might be addressed by ensuring subspecialty care in low-access regions, and/or adjusting system structures to minimize the burdens of traveling long distances for cancer care.
AB - Background Women who live distant from the closest subspecialty treatment center are at risk of failing to utilize high-quality care for gynecologic cancers. There has not yet been a comprehensive, national investigation of populations affected by geographic barriers to gynecologic cancer care. Methods Geographic Information Systems (GIS) were used to identify United States counties farther than 50 miles from the closest gynecologic oncologist, and hospital referral regions (HRRs) that do not contain the primary professional address of at least one gynecologic oncologist. US Census data were used to analyze counties' demographic characteristics. County-level cancer incidence was estimated using the Centers for Disease Control and Prevention's State Cancer Profiles. Results Thirty-six percent (1125/3143) of counties are further than 50 miles from the nearest gynecologic oncologist. A total of 14.8 million women live in low-access counties (LACs). Annually, approximately 7663 women with gynecologic cancers may experience geography-related disparities in access. Residents of LACs have lower median household income, are more likely to be White and/or Hispanic, and less likely to be Black. Forty percent (123/306) of HRRs do not contain the primary address of a gynecologic oncologist. Conclusions Approximately 9% of the female population of the United States may experience geographic barriers to access high-quality care for gynecologic malignancies. Future investigations should assess whether residents of low-access counties utilize high-quality care less often, and whether there is a disparity in clinical outcomes. Disparities might be addressed by ensuring subspecialty care in low-access regions, and/or adjusting system structures to minimize the burdens of traveling long distances for cancer care.
KW - Access disparities
KW - Cancer care delivery
KW - Health services research
UR - http://www.scopus.com/inward/record.url?scp=84937191274&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937191274&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2015.04.025
DO - 10.1016/j.ygyno.2015.04.025
M3 - Article
C2 - 25922191
AN - SCOPUS:84937191274
SN - 0090-8258
VL - 138
SP - 115
EP - 120
JO - Gynecologic oncology
JF - Gynecologic oncology
IS - 1
ER -